ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma (STEAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03224104
Recruitment Status : Recruiting
First Posted : July 21, 2017
Last Update Posted : June 8, 2018
Sponsor:
Collaborator:
Tragara Pharmaceuticals, Inc.
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2020
  Estimated Study Completion Date : August 2020